Evidence map›Paper›PMID 31771942›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2020

A Calcium-Rich Multimineral Intervention to Modulate Colonic Microbial Communities and Metabolomic Profiles in Humans: Results from a 90-Day Trial.

Muhammad N Aslam, Christine M Bassis, Ingrid L Bergin, Karsten Knuver, Suzanna M Zick, Ananda Sen, D Kim Turgeon, James Varani

2 registry-linked trialsOpen access · bronzeAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02647671 phase1completednot on this map

The Effects of Calcium in Conjunction With Multi-mineral Supplementation (Aquamin) on Gut Microbes and Microbially-derived Metabolites in Subjects at Risk for Colon Cancer in a Randomized Controlled Trial

TypeinterventionalSponsorJames VaraniRan2016 to 2021Enrolled36ConditionsColonic CancerArmsAquamin®, Calcium Carbonate, Placebo
NCT03869905 phase2active not recruitingnot on this map

Aquamin®, a Multi-mineral Natural Product From Red Marine Algae, as an Adjuvant Intervention for Mild Ulcerative Colitis and Ulcerative Colitis in Remission

TypeinterventionalSponsorMuhammad N Aslam, MDRan2019 to 2027Enrolled40ConditionsUlcerative ColitisArmsAquamin®, Placebo first then Aquamin®
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Muhammad N AslamDepartment of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan. mnaslam@med.umich.edu.ORCID 0000-0003-1361-5357
Christine M BassisDivision of Infectious Diseases, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0001-6047-0678
Ingrid L BerginThe Unit for Laboratory Animal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
Karsten KnuverDepartment of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan.
Suzanna M ZickDepartment of Family Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
Ananda SenDepartment of Family Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
D Kim TurgeonDivision of Gastroenterology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
James VaraniDepartment of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan.
University of Michigan · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RANDY J SEELEY · 2010 to 2026
$20.3M
Institutional Career Development CoreKL2TR002241 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELLINGROD, VICKI L · 2017 to 2021
$6.9M
NRSA Training CoreTL1TR002242 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2017 to 2021
$2.8M
Trace element supplementation to enhance calcium-mediated suppression of human colon adenoma growthR21CA201782 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VARANI, JAMES · 2016 to 2017
$526k
NCATS NIH HHS KL2 TR002241NCATS NIH HHS TL1 TR002242NCATS NIH HHS UL1 TR002240NCI NIH HHS R21 CA201782NIDDK NIH HHS P30 DK089503
6 · The paper itself

Abstract

Aquamin is a calcium-, magnesium-, and multiple trace element-rich natural product with colon polyp prevention efficacy based on preclinical studies. The goal of this study was to determine the effects of Aquamin on colonic microbial community and attendant metabolomic profile. Thirty healthy human participants were enrolled in a 90-day trial in which Aquamin (delivering 800 mg of calcium per day) was compared with calcium alone or placebo. Before and after the intervention, colonic biopsies and stool specimens were obtained. All 30 participants completed the study without serious adverse event or change in liver and renal function markers. Compared with pretreatment values, intervention with Aquamin led to a reduction in total bacterial DNA (

Indexed as

AdultAgedBile Acids and SaltsCalcium CarbonateColonColonic NeoplasmsDietary SupplementsDNA, BacterialFatty Acids, VolatileFecesFemaleGastrointestinal MicrobiomeHealthy VolunteersHumansIntestinal MucosaKidneyAquaminBile Acids and SaltsCalcium CarbonateDNA, BacterialFatty Acids, VolatileMinerals

Identifiers

PMID31771942
PMCPMC7528938
OpenAlexW2989935044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.